SecBot SecBot
144 ·Filed May 18, 2026

QUCY

Quantum Cyber N.V.
BEARISH
Impact 5/10
Horizondays Processed5mo ago SEC0001959173-26-003736
Form 144 — notice of proposed sale of securities
Actionable Insight ▼ Bearish

The sale of recently acquired shares by a policy-making officer suggests potential lack of confidence or need for liquidity. Monitor for any subsequent Form 4 filings to confirm execution of the sale, and watch for any negative catalysts in the near term.

DirectionBearish
Confidencemedium
Horizondays
Latest settled — T+20d ⚠ clustered
QUCY ▼ -24.60% at T+20d
SHORT call ✓ call won +24.60% · α vs SPY +25.59% · entry $2.52 → $1.90
Next anchor: T+60d due 3mo ago
Entry = T+0 close
May 18, 2026
via day close
T+1d
+30.56%
call -30.56% · α -29.52%
$3.29
settled 5mo ago
T+5d
+15.88%
call -15.88% · α -13.63%
$2.92
settled 5mo ago
T+20d
-24.60%
call +24.60% · α +25.59%
$1.90
settled 4mo ago
T+60d
Pending
due 3mo ago

Price Chart

Loading chart...

Executive Summary

Guido Baechler, a policy-making officer, filed a Form 144 indicating intent to sell 200,000 common shares (estimated value $692,000) of Quantum Cyber N.V. (QUCY). The shares were acquired via a stock award on April 22, 2026, just a month before the proposed sale date of May 15, 2026. This insider selling soon after receiving compensation is a bearish signal for the micro-cap biotech.

Key Facts

  • Insider Guido Baechler (policy-making officer) intends to sell 200,000 shares.
  • Estimated market value of proposed sale: $692,000.
  • Shares acquired as stock award on April 22, 2026.
  • Proposed sale date: May 15, 2026; filing date: May 18, 2026.
  • Market cap of QUCY: approximately $43 million; sale represents ~1.6% of market cap.

Financial Impact

Proposed sale of $692,000 in shares by an insider, representing 1.6% of market cap.

insider holdingsdilution

Risk Factors

  • Insider selling before potential negative news.
  • Possible further insider sales if the officer continues to reduce holdings.
  • Micro-cap biotech volatility; low liquidity could amplify price impact.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-003736
Document: 0001959173-26-003736-index.html0001959173-26-003736
Document: 0001959173-26-003736.txt0001959173-26-003736
35 reports for QUCY
Performance horizon
60% Hit rate @ T+20 3 of 5 directional calls Went positive at some point 4 of 6 best @ T+60▲ +39.06%Jun 4, 2026
Filters
Rows
Reports for QUCY — sortable, filterable
TypeNow
Oct 26, 2026
today
Press Release
NEUTRAL ★ 2/10
—awaiting T+20——
Oct 16, 2026
10d ago
8-K
NEUTRAL ★ 2/10
$1.07awaiting T+20—$1.01 (−5.61%)
Oct 9, 2026
17d ago
8-K
NEUTRAL ★ 4/10
$1.03awaiting T+20—$1.01 (−1.94%)
Oct 9, 2026
17d ago
424B5
BEARISH ★ 7/10
$1.03awaiting T+20—$1.01 (+1.94%)
Sep 28, 2026
28d ago
Press Release
NEUTRAL ★ 3/10
$1.36 $0.8515▼ −37.39%▼ −37.36%$1.01 (−25.74%)
Sep 25, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$1.37 $1.01▼ −26.28%▼ −24.80%$1.01 (−26.28%)
Sep 25, 2026
4w ago
Press Release
NEUTRAL ★ 3/10
$1.37 $1.01▼ −26.28%▼ −24.80%$1.01 (−26.28%)
Aug 13, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$1.42 $1.34▼ −5.63%▼ −3.89%$1.01 (−28.87%)
Jul 24, 2026
13w ago
8-K
NEUTRAL ★ 4/10
$1.08 $1.30▲ +20.37%▲ +16.74%$1.01 (−6.48%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 4/10
$1.19awaiting T+20—$1.01 (−15.13%)
Showing 10 of 35

US Market Status

Market Closed — Opens Wed (11h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 18, 2026